1-2 of 2
Maria-Elvira González Valentin
Close
Sort by
Journal Articles

One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

Albert Oriol, MD, Pilar Bastida, MD, Olga García, Carlota Calvo, Juan-Manuel Perez-Hurtado, Maria-Elvira González Valentin, Jose Luis Fuster, MD, Izaskun Egurbide, Victoria Martin-Reina, Antonio Molines, MD, Javier Lassaletta, Miguel-Angel Sanz, Mar Tormo, Mercedes Carnero, Juan-José Ortega, Josep-Maria Ribera, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2026.
https://doi.org/10.1182/blood.V114.22.2026.2026
Published: 2009
Journal Articles

Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Children with Very High-Risk Acute Lymphoblastic Leukemia (VHR-ALL). Final Results of the PETHEMA ALL-93 Trial.

Josep-Maria Ribera, PhD, Juan-Jose Ortega, MD, Albert Oriol, MD, Pilar Bastida, MD, Carlota Calvo, MD, Jose-María Perez-Hurtado, MD, Maria-Elvira González-Valentin, MD, Vicky Martin-Reina, MD, Antonio Molines, MD, Fernando Ortega-Rivas, MD, Maria-Pilar Queipo, MD, Concepción Rivas, MD, Izaskun Egurbide, MD, Inmaculada Heras, MD, Concepción Poderos, MD, Eva Martínez-Revuelta, MD, Jose-Maria Guinea, MD, Eloy del Potro, MD, Guillermo Deben, MD
Journal: Blood
Blood (2005) 106 (11): 173.
https://doi.org/10.1182/blood.V106.11.173.173
Published: 2005